The market for healthcare chatbots, which is expected to grow to be worth US$ 1.4 billion by 2024, is about to achieve a significant valuation. The primary factor propelling the expansion is the increasing awareness and understanding of the healthcare chatbot industry. With a predicted CAGR of 23.9% from 2024 to 2034, the trend is expected to provide new chances within the industry. It is anticipated that the market would reach a total worth of around US$12.2 billion by 2034.
With a host of features that enhance patient experiences and expedite medical procedures, healthcare chatbots have completely transformed the efficiency and accessibility of healthcare services.
One significant advantage of healthcare chatbots is their ability to reduce healthcare costs. Chatbots streamline administrative processes by automating routine tasks such as appointment scheduling, billing inquiries, and basic symptom assessments. This automation enhances operational efficiency and frees up valuable time for healthcare professionals. With routine tasks handled by chatbots, healthcare professionals can focus on more complex and critical patient needs, ultimately improving the overall quality of care.
Get a Sample Copy of this Report
Healthcare chatbots play a vital role in bridging the gap in healthcare access, particularly in underserved areas with limited medical facilities. By providing remote assistance and information, chatbots enable individuals in remote or rural locations to access healthcare resources and receive basic medical advice without needing physical travel. This can potentially improve health outcomes in areas with limited traditional healthcare access.
Healthcare chatbots leverage patient data and AI algorithms to deliver personalized healthcare services. By collecting and analyzing patient information, these chatbots can offer tailored recommendations, preventive care tips, and reminders for medication adherence. This personalized approach enhances patient engagement and empowers individuals to take proactive steps toward better health outcomes.
Key Takeaways from the Market Study
- The market valuation in 2023 was US$ 1.2 billion.
- Based on component, software is expected to dominate at a market share of 62% in 2024.
- China is estimated to register at a CAGR of 24.4% by 2034.
- Australia experiences significant growth, projected at a CAGR of 27.4% by 2034.
“Chatbots help to improve patient engagement by making it easier for patients to communicate with their healthcare providers and is considered as the market trend of the healthcare chatbot market,” opines Sudip Saha, managing director at Future Market Insights (FMI) analyst.
Competitive Landscape
The healthcare chatbot industry boasts a substantial array of market participants. Research and development play a pivotal role among these players, primarily focusing on introducing eco-friendly product lines as a core aspect of their manufacturing endeavors. Furthermore, they employ various expansion strategies, including collaborations, mergers and acquisitions, and diligent exploration of regulatory approvals to bolster their market presence.
Some of the key developments are
- In September 2023, HealthTap, a leading virtual healthcare provider delivering quality, affordable primary care across the U.S., launched a new version of its Dr.A.I.™ feature, a pre-appointment patient interview experience powered GPT-4.
- In June 2022, AI-powered health platform Buoy Health announced several exciting updates to its ongoing diversity, equity, inclusion, and accessibility (DEIA) efforts, including a recently awarded grant from the AWS Health Equity Initiative in recognition of LGBTQ+ Pride Month.
These developments further underscore Buoy’s mission to create more inclusive and accessible health solutions for everyone—especially those in underserved groups—by crafting personalized, holistic paths to care.
Key Companies Profiled
- Your.MD Ltd.
- HealthTap Inc.
- Sensely Inc.
- Buoy Health Inc.
- Infermedica
- Babylon Healthcare Service Limited
- Baidu Inc.
- Ada Digital Health Ltd.
- PACT Care BV
- Woebot Labs Inc.
- GYANT.Com Inc.
Key Segments of Healthcare Chatbots Industry Survey
By Component:
- Software
- Services
By Application:
- Appointment Scheduling
- Symptom Checking
- Medication Assistance & Guidance
- Others
By Deployment:
- On-premise
- Cloud
By End-user:
- Patients
- Insurance companies
- Healthcare providers
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East & Africa
Access Key Trends – Buy Now!
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube